[Clinical evaluation of kanamycin in the last 10 years].
D000818:Animals; D004352:Drug Resistance, Microbial; D004405:Dysentery, Bacillary / Q000188:drug therapy; D006801:Humans; D007239:Infections / Q000188:drug therapy; D007612:Kanamycin / Q000009:adverse effects / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D007612:Kanamycin